Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mohammed, Hamish"'
Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of gonorrhoea in the UK.
Autor:
Ladhani SN; Immunisation Division, UK Health Security Agency, London, UK; Centre for Neonatal and Paediatric Infection, St George's, University of London, London, UK. Electronic address: shamez.ladhani@ukhsa.gov.uk., White PJ; Modelling and Economics Unit, UK Health Security Agency, London, UK; MRC Centre for Global Infectious Disease Analysis, Imperial College School of Public Health, London, UK., Campbell H; Immunisation Division, UK Health Security Agency, London, UK., Mandal S; Immunisation Division, UK Health Security Agency, London, UK., Borrow R; Meningococcal Reference Unit, UK Health Security Agency, Manchester Royal Infirmary, Manchester, UK., Andrews N; Statistics, Modelling, and Economics Department, UK Health Security Agency, London, UK., Bhopal S; Immunisation Division, UK Health Security Agency, London, UK., Saunders J; Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK., Mohammed H; Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK., Drisdale-Gordon L; Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK., Callan E; Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK., Sinka K; Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK., Folkard K; Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK., Fifer H; Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK., Ramsay ME; Immunisation Division, UK Health Security Agency, London, UK.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Mar 20. Date of Electronic Publication: 2024 Mar 20.
Autor:
Zhang XS; Statistics, Modelling and Economics, Data, Analytics and Surveillance, UK Health Security Agency, London, UK., Mandal S; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK; Blood Safety, Hepatitis, Sexually Transmitted Infections and HIV Division, UK Health Security Agency, London, UK., Mohammed H; Blood Safety, Hepatitis, Sexually Transmitted Infections and HIV Division, UK Health Security Agency, London, UK; Institute for Global Health, University College London, London, UK; National Institute for Health and Care Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency, London, UK., Turner C; Health Protection Operations, UK Health Security Agency, London, UK., Florence I; Health Protection Operations, UK Health Security Agency, London, UK., Walker J; Population Health Sciences, University of Bristol, Bristol, UK., Niyomsri S; Population Health Sciences, University of Bristol, Bristol, UK., Amirthalingam G; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Ramsay M; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Charlett A; Statistics, Modelling and Economics, Data, Analytics and Surveillance, UK Health Security Agency, London, UK., Vickerman P; Population Health Sciences, University of Bristol, Bristol, UK; National Institute for Health and Care Research Health Protection Research Unit in Behavioural Science and Evaluation at the University of Bristol in partnership with UK Health Security Agency, Bristol, UK. Electronic address: peter.vickerman@bristol.ac.uk.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Jan; Vol. 24 (1), pp. 65-74. Date of Electronic Publication: 2023 Sep 11.
Autor:
Bertran M; Immunisations and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Andrews N; Immunisations and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Davison C; Immunisations and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Dugbazah B; Immunisations and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Boateng J; Immunisations and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Lunt R; Immunisations and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Hardstaff J; Monkeypox Data, Epidemiology and Analytics Cell, UK Health Security Agency, London, UK., Green M; Monkeypox Data, Epidemiology and Analytics Cell, UK Health Security Agency, London, UK., Blomquist P; Monkeypox Data, Epidemiology and Analytics Cell, UK Health Security Agency, London, UK., Turner C; Monkeypox Data, Epidemiology and Analytics Cell, UK Health Security Agency, London, UK., Mohammed H; Division of Blood Safety, Hepatitis, STIs and HIV, UK Health Security Agency, London, UK; Institute for Global Health, University College London, London, UK., Cordery R; Immunisations and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Mandal S; Immunisations and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Campbell C; Immunisations and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Ladhani SN; Immunisations and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK; Paediatric Infectious Diseases Research Group, St. George's University of London, London, UK., Ramsay M; Immunisations and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Amirthalingam G; Immunisations and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Bernal JL; Immunisations and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK. Electronic address: jamie.lopezbernal2@ukhsa.gov.uk.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Jul; Vol. 23 (7), pp. 828-835. Date of Electronic Publication: 2023 Mar 13.
Autor:
Town K; National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections, University College London, London, UK; Centre for Molecular Epidemiology and Translational Research, Institute for Global Health, University College London, London, UK; National Infection Service, Public Health England, London, UK. Electronic address: katy.town.15@alumni.ucl.ac.uk., Field N; Centre for Molecular Epidemiology and Translational Research, Institute for Global Health, University College London, London, UK., Harris SR; Microbiotica, Biodata Innovation Centre, Hinxton, UK., Sánchez-Busó L; Centre for Genomic Pathogen Surveillance, Wellcome Sanger Institute, Hinxton, UK; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Cole MJ; National Infection Service, Public Health England, London, UK., Pitt R; National Infection Service, Public Health England, London, UK., Fifer H; National Infection Service, Public Health England, London, UK., Mohammed H; National Infection Service, Public Health England, London, UK., Hughes G; National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections, University College London, London, UK; National Infection Service, Public Health England, London, UK.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2020 Apr; Vol. 20 (4), pp. 478-486. Date of Electronic Publication: 2020 Jan 21.